Annual Current Liabilities
$1.66 M
-$1.42 M-46.18%
December 31, 2023
Summary
- As of February 8, 2025, FRTX annual total current liabilities is $1.66 million, with the most recent change of -$1.42 million (-46.18%) on December 31, 2023.
- During the last 3 years, FRTX annual current liabilities has fallen by -$4.70 million (-73.93%).
- FRTX annual current liabilities is now -90.21% below its all-time high of $16.92 million, reached on December 1, 2017.
Performance
FRTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$1.66 M
-$452.00 K-21.44%
December 31, 2023
Summary
- As of February 8, 2025, FRTX quarterly total current liabilities is $1.66 million, with the most recent change of -$452.00 thousand (-21.44%) on December 31, 2023.
- Over the past year, FRTX quarterly current liabilities has dropped by -$452.00 thousand (-21.44%).
- FRTX quarterly current liabilities is now -90.21% below its all-time high of $16.92 million, reached on December 1, 2017.
Performance
FRTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
FRTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.2% | -21.4% |
| 3 y3 years | -73.9% | -21.4% |
| 5 y5 years | -53.8% | -21.4% |
FRTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.6% | at low | -65.6% | at low |
| 5 y | 5-year | -84.2% | at low | -84.2% | at low |
| alltime | all time | -90.2% | +84.0% | -90.2% | +84.0% |
Fresh Tracks Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $1.66 M(-46.2%) | $1.66 M(-21.4%) |
| Sep 2023 | - | $2.11 M(+13.9%) |
| Jun 2023 | - | $1.85 M(-11.9%) |
| Mar 2023 | - | $2.10 M(-31.7%) |
| Dec 2022 | $3.08 M(-36.0%) | $3.08 M(-4.6%) |
| Sep 2022 | - | $3.22 M(+12.3%) |
| Jun 2022 | - | $2.87 M(-39.5%) |
| Mar 2022 | - | $4.74 M(-1.4%) |
| Dec 2021 | $4.81 M(-24.3%) | - |
| Dec 2021 | - | $4.81 M(+14.5%) |
| Sep 2021 | - | $4.20 M(-37.1%) |
| Jun 2021 | - | $6.68 M(-28.7%) |
| Mar 2021 | - | $9.38 M(+47.7%) |
| Dec 2020 | $6.35 M(-39.5%) | $6.35 M(-15.5%) |
| Sep 2020 | - | $7.51 M(+3.7%) |
| Jun 2020 | - | $7.25 M(+2.2%) |
| Mar 2020 | - | $7.09 M(-32.4%) |
| Dec 2019 | $10.50 M(+193.1%) | $10.50 M(+43.7%) |
| Sep 2019 | - | $7.30 M(+530.3%) |
| Jun 2019 | - | $1.16 M(-54.0%) |
| Mar 2019 | - | $2.52 M(-29.6%) |
| Dec 2018 | $3.58 M(-78.8%) | $3.58 M(+1.4%) |
| Sep 2018 | - | $3.53 M(+11.0%) |
| Jun 2018 | - | $3.18 M(+0.8%) |
| Mar 2018 | - | $3.16 M(-81.3%) |
| Dec 2017 | $16.92 M(+136.8%) | $16.92 M(+42.4%) |
| Sep 2017 | - | $11.88 M(+8.2%) |
| Jun 2017 | - | $10.98 M(+24.0%) |
| Mar 2017 | - | $8.86 M(+23.9%) |
| Dec 2016 | $7.14 M(+71.7%) | $7.14 M(+80.2%) |
| Sep 2016 | - | $3.96 M(+19.7%) |
| Jun 2016 | - | $3.31 M(-8.7%) |
| Mar 2016 | - | $3.63 M(-12.8%) |
| Dec 2015 | $4.16 M(-20.0%) | $4.16 M(-24.0%) |
| Sep 2015 | - | $5.47 M(+20.4%) |
| Jun 2015 | - | $4.54 M(+10.1%) |
| Mar 2015 | - | $4.13 M(-20.6%) |
| Dec 2014 | $5.20 M(+42.4%) | $5.20 M(+12.1%) |
| Sep 2014 | - | $4.64 M(+22.3%) |
| Jun 2014 | - | $3.79 M(+13.7%) |
| Mar 2014 | - | $3.33 M(-8.8%) |
| Dec 2013 | $3.65 M(-36.8%) | $3.65 M(-29.9%) |
| Sep 2013 | - | $5.21 M(-14.0%) |
| Jun 2013 | - | $6.06 M(+14.8%) |
| Mar 2013 | - | $5.28 M(-8.7%) |
| Dec 2012 | $5.78 M(-10.6%) | $5.78 M(+3.4%) |
| Sep 2012 | - | $5.59 M(+10.4%) |
| Jun 2012 | - | $5.06 M(-30.3%) |
| Mar 2012 | - | $7.27 M(+12.5%) |
| Dec 2011 | $6.46 M(+2.0%) | $6.46 M(+17.8%) |
| Sep 2011 | - | $5.48 M(-3.3%) |
| Jun 2011 | - | $5.67 M(+4.3%) |
| Mar 2011 | - | $5.44 M(-14.2%) |
| Dec 2010 | $6.33 M(-36.7%) | $6.33 M(-8.0%) |
| Sep 2010 | - | $6.89 M(-0.3%) |
| Jun 2010 | - | $6.91 M(-12.1%) |
| Mar 2010 | - | $7.86 M(-21.5%) |
| Dec 2009 | $10.01 M(+25.5%) | $10.01 M(+5.7%) |
| Sep 2009 | - | $9.47 M(+6.2%) |
| Jun 2009 | - | $8.92 M(+12.7%) |
| Mar 2009 | - | $7.91 M(-0.8%) |
| Dec 2008 | $7.97 M | $7.97 M(+6.0%) |
| Sep 2008 | - | $7.52 M(-0.7%) |
| Jun 2008 | - | $7.57 M(+26.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $5.97 M(-26.4%) |
| Dec 2007 | $8.11 M(-0.6%) | $8.11 M(+40.6%) |
| Sep 2007 | - | $5.77 M(+4.9%) |
| Jun 2007 | - | $5.50 M(-17.9%) |
| Mar 2007 | - | $6.70 M(-17.8%) |
| Dec 2006 | $8.15 M(-7.1%) | $8.15 M(+18.1%) |
| Sep 2006 | - | $6.90 M(+7.7%) |
| Jun 2006 | - | $6.41 M(-14.3%) |
| Mar 2006 | - | $7.47 M(-14.9%) |
| Dec 2005 | $8.78 M(-13.1%) | $8.78 M(-4.9%) |
| Sep 2005 | - | $9.23 M(-4.3%) |
| Jun 2005 | - | $9.65 M(+16.7%) |
| Mar 2005 | - | $8.26 M(-18.2%) |
| Dec 2004 | $10.11 M(-17.3%) | $10.11 M(+12.3%) |
| Sep 2004 | - | $9.00 M(-14.0%) |
| Jun 2004 | - | $10.47 M(-13.2%) |
| Mar 2004 | - | $12.06 M(-1.3%) |
| Dec 2003 | $12.22 M(+13.2%) | $12.22 M(+4.5%) |
| Sep 2003 | - | $11.69 M(-14.6%) |
| Jun 2003 | - | $13.69 M(+30.4%) |
| Mar 2003 | - | $10.50 M(-2.8%) |
| Dec 2002 | $10.80 M(+38.6%) | $10.80 M(+14.1%) |
| Sep 2002 | - | $9.47 M(+18.4%) |
| Jun 2002 | - | $7.99 M(+14.6%) |
| Mar 2002 | - | $6.97 M(-10.5%) |
| Dec 2001 | $7.79 M(+11.5%) | $7.79 M(-5.5%) |
| Sep 2001 | - | $8.25 M(+15.3%) |
| Jun 2001 | - | $7.16 M(+5.2%) |
| Mar 2001 | - | $6.80 M(-2.7%) |
| Dec 2000 | $6.99 M(+22.6%) | $6.99 M(+26.3%) |
| Sep 2000 | - | $5.53 M(-13.1%) |
| Jun 2000 | - | $6.36 M(+14.0%) |
| Mar 2000 | - | $5.58 M(-2.1%) |
| Dec 1999 | $5.70 M(+78.1%) | $5.70 M(+32.6%) |
| Sep 1999 | - | $4.30 M(+13.2%) |
| Jun 1999 | - | $3.80 M(+2.7%) |
| Mar 1999 | - | $3.70 M(+15.6%) |
| Dec 1998 | $3.20 M(+39.1%) | $3.20 M(+14.3%) |
| Sep 1998 | - | $2.80 M(0.0%) |
| Jun 1998 | - | $2.80 M(+27.3%) |
| Mar 1998 | - | $2.20 M(-4.3%) |
| Dec 1997 | $2.30 M(-8.0%) | $2.30 M(+21.1%) |
| Sep 1997 | - | $1.90 M(-5.0%) |
| Jun 1997 | - | $2.00 M(+5.3%) |
| Mar 1997 | - | $1.90 M(-24.0%) |
| Dec 1996 | $2.50 M(+66.7%) | $2.50 M(0.0%) |
| Sep 1996 | - | $2.50 M(+47.1%) |
| Jun 1996 | - | $1.70 M(+30.8%) |
| Mar 1996 | - | $1.30 M(-13.3%) |
| Dec 1995 | $1.50 M(-21.1%) | $1.50 M(0.0%) |
| Sep 1995 | - | $1.50 M(+36.4%) |
| Jun 1995 | - | $1.10 M(-15.4%) |
| Mar 1995 | - | $1.30 M(-31.6%) |
| Dec 1994 | $1.90 M(-13.6%) | $1.90 M(+5.6%) |
| Sep 1994 | - | $1.80 M(0.0%) |
| Jun 1994 | - | $1.80 M(+20.0%) |
| Mar 1994 | - | $1.50 M(-31.8%) |
| Dec 1993 | $2.20 M(-29.0%) | $2.20 M(+4.8%) |
| Sep 1993 | - | $2.10 M(-22.2%) |
| Jun 1993 | - | $2.70 M(+107.7%) |
| Mar 1993 | - | $1.30 M(-58.1%) |
| Dec 1992 | $3.10 M(+138.5%) | $3.10 M(+138.5%) |
| Dec 1991 | $1.30 M(+44.4%) | $1.30 M(+44.4%) |
| Dec 1990 | $900.00 K | $900.00 K |
FAQ
- What is Fresh Tracks Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual current liabilities year-on-year change?
- What is Fresh Tracks Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly current liabilities year-on-year change?
What is Fresh Tracks Therapeutics annual total current liabilities?
The current annual current liabilities of FRTX is $1.66 M
What is the all time high annual current liabilities for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual total current liabilities is $16.92 M
What is Fresh Tracks Therapeutics annual current liabilities year-on-year change?
Over the past year, FRTX annual total current liabilities has changed by -$1.42 M (-46.18%)
What is Fresh Tracks Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of FRTX is $1.66 M
What is the all time high quarterly current liabilities for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly total current liabilities is $16.92 M
What is Fresh Tracks Therapeutics quarterly current liabilities year-on-year change?
Over the past year, FRTX quarterly total current liabilities has changed by -$452.00 K (-21.44%)